总的来说，该研究为 ACEi 和 ARBs 在预防 CTRC 方面的应用提供了重要参考，尽管未能明确其预防 CTRC 的效果，但在改善左心室功能方面的发现为后续研究指明了方向，有望推动癌症治疗中心脏保护策略的进一步发展。

In addition to their capacity to lower systemic blood pressure, angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) are thought to have specific ...

Angiotensin-converting enzyme (ACE ... How strong is the evidence that these drugs are more renoprotective than other antihypertensive agents? In a meta-analysis, investigators reviewed 127 ...

The global IgA nephropathy disease treatment market is poised for substantial growth, with projections indicating a robust CAGR of 20.8% during the forecast period from 2022 to 2028. This growth is ...

Scientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.

Angiotensin receptor blockers (ARBs) are a class of oral medications that act primarily through blockade of the angiotensin receptor. The effects of angiotensin include vasoconstriction and ...

Angiotensin II has complex effects on the heart ... The initial form of the drug (clinically active or requiring metabolic activation) is unrelated to efficacy, except in a few patients who ...